HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Coty Eyes OPI Growth; RevitaLash Is Back; Garnier Pulled From China

This article was originally published in The Rose Sheet

Executive Summary

Coty aims to drive development of its OPI nail brand in the U.K. with the acquisition of distributor Lena White. More news in brief.

Advertisement

Related Content

Preemption Argument In Drug/Cosmetic Dispute Likely Falls Short Of Supreme Court
Preemption Argument In Drug/Cosmetic Dispute Likely Falls Short Of Supreme Court
Supreme Court Review Of Athena Cosmetics Case, Federal Preemption Argument Unlikely
Supreme Court Asked To Consider Pre-emption In Drug Vs. Cosmetic Litigation
Supreme Court Asked To Consider Pre-emption In Drug Vs. Cosmetic Litigation
Supreme Court May Hear Cosmetics Case Exploring Federal Preemption
Global Players Reevaluate In China As Local Competition Intensifies
In Brief: FDA Seeks Cosmetics Comments; L’Oreal/Magic Deal Approved; More
In Brief

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS019027

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel